Quantitative comparison method for detecting fragile X syndrome based on methylation level and primer used in quantitative comparison method
A technology for X chromosome and syndrome, which is applied in the field of detection of congenital genetic defect Fragile X chromosome syndrome, can solve the problems of inability to realize quantitative detection and immature method for quantitative detection of abnormal methylation of FMR1 promoter
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0095] Example 1: Patient A with suspected fragile X syndrome.
[0096] 1. Obtain clinical samples and set up experimental and control groups
[0097] 1) Patient
[0098] The sample of male patient A came from a tertiary hospital, clinically manifested as mental retardation, and the preliminary diagnosis of big ears was Fragile X syndrome.
[0099] 2) Control group
[0100] Three normal men and three normal women were selected as the control group.
[0101] 2. Experimental scheme and steps
[0102] 1. Primer design: such as figure 1 As shown in a, the CpG island transcriptional regulatory region within the 300 to 100 bp region upstream of exon 1 of the FMR1 gene is selected as the methylation detection region, and the sequence is as follows figure 1 As shown in b. Amplification primers were designed for regions that do not involve CpG sites, in order to avoid amplification bias due to unknown methylation levels. The downstream amplification primers need to be labeled ...
Embodiment 2
[0149] Example 2: Patient B with suspected fragile X syndrome.
[0150] Detect according to the method described in Example 1, and the detection results are as follows:
[0151] 1. Pyrosequencing experiment results ( Figure 5 )
[0152] Each shaded area represents a CpG site, the percentage of C and T on the upper end represents the amount of the two nucleotides detected, and the ratio of C represents the proportion of methylation at this site. There are 5 ABCDE sites in total. Figure 5 a shows that the methylation levels of 5 ABCDE sites in suspected patient B are 58%, 65%, 66%, 73%, and 63%, respectively. Figure 5 b shows that the normal male control ABCDE5 methylation levels are 26%, 29%, 32%, 34%, 31%.
[0153] 2. Statistical analysis, data collation list.
[0154]
[0155] 3. Statistically analyze the above data using chi-square test, the results are as follows:
[0156] A(chi-square) B(chi-square) C(chi-square) D(chi-square) E(chi-square) ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com